Hong Kong's Biosimilar Registration Requirements To Kick In From Jan. 1
This article was originally published in SRA
Executive Summary
Hong Kong's Pharmacy and Poisons Board has issued its first ever guidance1,2 on the evaluation and registration of biosimilar products, which will come into effect on Jan. 1, 2016.